Dianthus Therapeutics, Inc. (DNTH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.56B |
| Enterprise Value | 1.51B |
| P/E Ratio | -866.82 |
| PEG Ratio | -12,799.05 |
| Price/Sales Ratio | 2,979.69 |
| Price/Book Ratio | 3.81 |
| Enterprise/Revenue | 2,510.9 |
| Enterprise/EBITDA | -308.83 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -8.48 |
| Operating Margin | -143.18 |
| Return On Assets | -0.01 |
| Return On Equity | -0.02 |
| Revenue | 2.04M |
| Revenue/Share | 0.03 |
| Gross Profit | 2.04M |
| EBITDA | -161.91M |
| Net Income | -162.34M |
| Diluted EPS | -4.2 |
| Total Cash | 1.11B |
| Total Cash/Share | 23.14 |
| Total Debt | 1.36M |
| Total Debt/Equity | 0 |
| Current Ratio | 29.25 |
| Book Value Per Share | 25.01 |
| 52-Week Change | 368.55 |
| 52-Week High | 102.37 |
| 52-Week Low | 18.08 |
| Moving Average 50 Days | 88.65 |
| Moving Average 200 Days | 62.86 |
| Average Volume | 942,935 |
| Shares Outstanding | 41.75M |
| % Held by Institutions | 164.38 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:16 |
| Last Split Date | September 12, 2023 |